0001971887-26-000003.txt : 20260806 0001971887-26-000003.hdr.sgml : 20260806 20260806083459 ACCESSION NUMBER: 0001971887-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260806 DATE AS OF CHANGE: 20260806 EFFECTIVENESS DATE: 20260806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InnovoTEX Inc. CENTRAL INDEX KEY: 0001971887 ORGANIZATION NAME: EIN: 882134906 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-593292 FILM NUMBER: 261246256 BUSINESS ADDRESS: STREET 1: 3800 NORTH LAMAR BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 570-510-6372 MAIL ADDRESS: STREET 1: 3800 NORTH LAMAR BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: InnovTEX Inc. DATE OF NAME CHANGE: 20230331 D 1 primary_doc.xml X0708 D LIVE 0001971887 InnovoTEX Inc. 3800 NORTH LAMAR BLVD. SUITE 200 AUSTIN TX TEXAS 78756 570-510-6372 DELAWARE InnovTEX Inc. Corporation true 2022 Krystle Karoscik 3800 North Lamar Blvd., Suite 200 Austin TX TEXAS 78756 Executive Officer Director Jonathan Arambula 3800 North Lamar Blvd., Suite 200 Austin TX TEXAS 78756 Director Jonathan Sessler 3800 North Lamar Blvd., Suite 200 Austin TX TEXAS 78756 Director James Hussey 3800 North Lamar Blvd., Suite 200 Austin TX TEXAS 78756 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-19 true true false 0 4000000 749951 3250049 false 14 0 0 0 true no additional amounts will be paid to any such persons beyond what is due to those who are employees pursuant to the terms of their employment. false InnovoTEX Inc. Krystle Karoscik Krystle Karoscik Chief Executive Officer 2026-08-06